Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Moderna vaccine induces robust immune response against SARS-CoV-2

The race to develop an effective vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on, and one of the potential candidates shows promise in inducing an immune response.

15 Jul 2020

Nanotechnology plays major role in COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

15 Jul 2020

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19.

From Absolute Antibody Ltd 14 Jul 2020

New MET ONE 3400+ air particle counter automates routine environmental monitoring for GMP cleanroom compliance

Beckman Coulter Life Sciences announced today that the MET ONE 3400+ portable air particle counter is now available to help GMP cleanroom users simplify their routine environmental monitoring and improve data integrity.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 14 Jul 2020

NUS teams develop three nasopharyngeal swab designs for COVID-19 testing

Since the outbreak of COVID-19, there has been a global surge in demand for nasopharyngeal (NP) swabs, a key element in testing for SARS-CoV-2. Singapore is no exception. Commercially available NP swabs used in COVID-19 test kits are often out of stock due to supply chain disruptions.

13 Jul 2020

FIND and Unitaid launch call for EOI to fill major diagnostic gaps in COVID-19 detection

The Foundation for Innovative New Diagnostics and Unitaid announced today that the organizations have launched a call for expressions of interest to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens. Reliable, affordable Ag RDTs have been identified as key tools in the global response to COVID-19, as they could enable robust detection of active SARS-CoV-2 infection for both patient management and contact tracing purposes in decentralized settings.

10 Jul 2020

Colorado School of Public Health's Center for Health, Work & Environment receives $9 million CDC grant

The Center for Health, Work & Environment at the Colorado School of Public Health has been awarded a $9 million five-year training and research grant from the Centers for Disease Control and Prevention to improve worker health, safety and well-being.

9 Jul 2020

UniSA researchers pioneer new method to more accurately diagnose Parkinson’s disease

University of South Australia researchers are pioneering a new method to more accurately diagnose Parkinson’s disease, a neurodegenerative brain disorder which affects around 70,000 Australians, resulting in a loss of control of body movements.

9 Jul 2020

BIA Separations signs new distribution agreements with two companies in Asia

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced it has signed agreements with Bioscience companies, GeneX India Biosciences Pvt. Ltd. and IT Technologies Pte. Ltd.

9 Jul 2020

$50 million NIST funding to support U.S. manufacturers in their response to COVID-19

The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has awarded a total of $50 million in emergency funding to support U.S. manufacturers in their response to the COVID-19 pandemic.

8 Jul 2020

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Jul 2020

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

8 Jul 2020

Brigham experts develop reusable N95 mask alternative

With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.

8 Jul 2020

World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19

In the race to find new ways to prevent and treat COVID-19, Canadian researchers have launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations - cancer patients.

8 Jul 2020

Characterizing Polymorphs and Amorphous Form

Dr. Matteo Daldosso and Dr. Sebastian Wegner discuss novel solutions for the characterization of polymorphs and amorphous form APIs.

From Bruker BioSpin - NMR, EPR and Imaging 8 Jul 2020

Study sheds new light on protein movement

Many of the most promising medicines under development are proteins, often antibodies, to help patients fight disease. These proteins must be purified as part of the manufacturing process -; a task that can be tricky and result in costly waste.

8 Jul 2020

Oxford COVID-19 vaccine trials move to stage 3 human trials

The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.

5 Jul 2020

BBI Solutions reaches 'major milestone' in development of COVID-19 lateral flow antibody test

BBI Solutions, part of the UK-Rapid Test Consortium, has reached a ‘major milestone’ in the development of a COVID-19 lateral flow antibody test.

3 Jul 2020

MSC Software releases new tool to help surgeons design medical devices like an engineer

MSC Software Corporation, a global leader in Computer-Aided Engineering simulation software and services and part of Hexagon's Manufacturing Intelligence division, has released MSC Apex Generative Design 2020, a pioneering tool that enables engineers to explore new approaches and optimize any part of their design in a single step to develop innovative products up to 80% faster than conventional approaches.

3 Jul 2020

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

In a recent medRxiv* paper, a research group from the U.S. and Germany showed a robust immunogenic response and a promising safety profile of the novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) – actively encouraging its accelerated clinical development and potential rapid production.

2 Jul 2020

Manufacturing News and Research

Further Reading

Moderna vaccine induces robust immune response against SARS-CoV-2

Nanotechnology plays major role in COVID-19 vaccine development

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

New MET ONE 3400+ air particle counter automates routine environmental monitoring for GMP cleanroom compliance

NUS teams develop three nasopharyngeal swab designs for COVID-19 testing

FIND and Unitaid launch call for EOI to fill major diagnostic gaps in COVID-19 detection

Colorado School of Public Health's Center for Health, Work & Environment receives $9 million CDC grant

UniSA researchers pioneer new method to more accurately diagnose Parkinson’s disease

BIA Separations signs new distribution agreements with two companies in Asia

$50 million NIST funding to support U.S. manufacturers in their response to COVID-19

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

Brigham experts develop reusable N95 mask alternative

World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19

Characterizing Polymorphs and Amorphous Form

Study sheds new light on protein movement

Oxford COVID-19 vaccine trials move to stage 3 human trials

BBI Solutions reaches 'major milestone' in development of COVID-19 lateral flow antibody test

MSC Software releases new tool to help surgeons design medical devices like an engineer

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News